Table 3.
Characteristics | Total | HCP5 | P value | |
---|---|---|---|---|
High expression n = 49 | Low expression n = 49 | |||
Gender | 0.306 | |||
Male | 57 | 31 | 26 | |
Female | 41 | 18 | 23 | |
Age (years) | 0.541 | |||
≥60 | 43 | 20 | 23 | |
<60 | 55 | 29 | 26 | |
Differentiation | 0.026* | |||
Poorly/moderately poorly | 53 | 32 | 21 | |
Well/medium-well | 45 | 17 | 28 | |
Tumor size (cm) | 0.258 | |||
≥5 | 27 | 11 | 16 | |
<5 | 71 | 38 | 33 | |
TNM stage | 0.840 | |||
TI-TII | 51 | 26 | 25 | |
TIII-TIV | 47 | 23 | 24 | |
Lymph node metastasis | 0.043* | |||
Positive | 50 | 30 | 20 | |
Negative | 48 | 19 | 29 | |
Distant metastasis | 0.106 | |||
Positive | 50 | 29 | 21 | |
Negative | 48 | 20 | 28 | |
Nerve invasion | 0.026* | |||
Positive | 51 | 31 | 20 | |
Negative | 47 | 18 | 29 | |
CEA (ng/ml) | 0.389 | |||
≥5.0 | 66 | 35 | 31 | |
<5.0 | 32 | 14 | 18 |
Statistical analyses were carried out using Pearson χ2 test. *P < 0.05 was considered significant.